{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:56:15Z","timestamp":1790420175186,"version":"4.1.0"},"publisher-location":"Cham","reference-count":149,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030806132","type":"print"},{"value":"9783030806149","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-80614-9_7","type":"book-chapter","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T04:03:06Z","timestamp":1637553786000},"page":"161-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-\u03b2 Signaling"],"prefix":"10.1007","author":[{"given":"Jason B.","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Ikonomidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M (2006) Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43:97\u2013110","journal-title":"J Med Genet"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ajmg.1320570410","volume":"57","author":"LC Ades","year":"1995","unstructured":"Ades LC, Morris LL, Power RG et al (1995) Distinct skeletal abnormalities in four girls with Shprintzen-Goldberg syndrome. Am J Med Genet 57:565\u2013572","journal-title":"Am J Med Genet"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ajmg.a.31202","volume":"140","author":"LC Ades","year":"2006","unstructured":"Ades LC, Sullivan K, Biggin A et al (2006) FBN1, TGFBR1, and the Marfan-craniosynostosis\/mental retardation disorders revisited. Am J Med Genet A 140:1047\u20131058","journal-title":"Am J Med Genet A"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1253\/circj.71.1305","volume":"71","author":"K Akutsu","year":"2007","unstructured":"Akutsu K, Morisaki H, Takeshita S et al (2007) Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta receptor genes. Circulat J Off J Japanese Circulat Soc 71:1305\u20131309","journal-title":"Circulat J Off J Japanese Circulat Soc"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/ajmg.a.33968","volume":"155A","author":"S Andrabi","year":"2011","unstructured":"Andrabi S, Bekheirnia MR, Robbins-Furman P et al (2011) SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am J Med Genet A 155A:1165\u20131169","journal-title":"Am J Med Genet A"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1242\/jcs.00229","volume":"116","author":"JP Annes","year":"2003","unstructured":"Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116:217\u2013224","journal-title":"J Cell Sci"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1161\/CIRCULATIONAHA.109.887042","volume":"120","author":"D Attias","year":"2009","unstructured":"Attias D, Stheneur C, Roy C et al (2009) Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 120:2541\u20132549","journal-title":"Circulation"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ajhg.2014.10.018","volume":"95","author":"M Barbier","year":"2014","unstructured":"Barbier M, Gross MS, Aubart M et al (2014) MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 95:736\u2013743","journal-title":"Am J Hum Genet"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/513903","volume":"61","author":"JN Berg","year":"1997","unstructured":"Berg JN, Gallione CJ, Stenzel TT et al (1997) The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60\u201367","journal-title":"Am J Hum Genet"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"585S","DOI":"10.1378\/chest.128.6_suppl.585S","volume":"128","author":"P Bertolino","year":"2005","unstructured":"Bertolino P, Deckers M, Lebrin F et al (2005) Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 128:585S\u2013590S","journal-title":"Chest"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0741-5214(97)70261-1","volume":"25","author":"A Biddinger","year":"1997","unstructured":"Biddinger A, Rocklin M, Coselli J et al (1997) Familial thoracic aortic dilatations and dissections: a case control study. J Vasc Surg 25:506\u2013511","journal-title":"J Vasc Surg"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/1533331","volume":"44","author":"A Bideau","year":"1989","unstructured":"Bideau A, Plauchu H, Brunet G et al (1989) Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population 44:3\u201322","journal-title":"Population"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI8088","volume":"104","author":"A Bourdeau","year":"1999","unstructured":"Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343\u20131351","journal-title":"J Clin Invest"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/01.CIR.0000121741.50315.C2","volume":"109","author":"P Boutouyrie","year":"2004","unstructured":"Boutouyrie P, Germain DP, Fiessinger JN et al (2004) Increased carotid wall stress in vascular Ehlers-Danlos syndrome. Circulation 109:1530\u20131535","journal-title":"Circulation"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0945-053X(00)00133-5","volume":"19","author":"RA Brekken","year":"2001","unstructured":"Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19:816\u2013827","journal-title":"Matrix Biol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/hrt.51.2.220","volume":"51","author":"L Bruno","year":"1984","unstructured":"Bruno L, Tredici S, Mangiavacchi M et al (1984) Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J 51:220\u2013230","journal-title":"Br Heart J"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/dvg.20409","volume":"46","author":"BL Callewaert","year":"2008","unstructured":"Callewaert BL, Loeys BL, Casteleyn C et al (2008) Absence of arterial phenotype in mice with homozygous slc2A10 missense substitutions. Genesis 46:385\u2013389","journal-title":"Genesis"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta L, Smaldone S, Zilberberg L et al (2009) p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem 284:5630\u20135636","journal-title":"J Biol Chem"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","volume":"102","author":"AW Chung","year":"2008","unstructured":"Chung AW, Yang HH, Radomski MW et al (2008) Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102:e73\u2013e85","journal-title":"Circ Res"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2174\/138161206776361336","volume":"12","author":"A Cirulli","year":"2006","unstructured":"Cirulli A, Loria MP, Dambra P et al (2006) Patients with hereditary hemorrhagic Telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT. Curr Pharm Des 12:1209\u20131215","journal-title":"Curr Pharm Des"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archsurg.134.4.361","volume":"134","author":"MA Coady","year":"1999","unstructured":"Coady MA, Davies RR, Roberts M et al (1999) Familial patterns of thoracic aortic aneurysms. Arch Surg 134:361\u2013367","journal-title":"Arch Surg"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ajmg.a.30838","volume":"137","author":"JH Cohen","year":"2005","unstructured":"Cohen JH, Faughnan ME, Letarte M et al (2005) Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A 137:153\u2013160","journal-title":"Am J Med Genet A"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jmg.2004.028712","volume":"42","author":"SG Cole","year":"2005","unstructured":"Cole SG, Begbie ME, Wallace GM et al (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42:577\u2013582","journal-title":"J Med Genet"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00403-019-01894-0","volume":"311","author":"F Cortini","year":"2019","unstructured":"Cortini F, Villa C, Marinelli B et al (2019) Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing. Arch Dermatol Res 311:265\u2013275","journal-title":"Arch Dermatol Res"},{"key":"7_CR25","doi-asserted-by":"crossref","unstructured":"Costanza B, Umelo IA, Bellier J et al (2017) Stromal modulators of TGF-beta in Cancer. J Clin Med 6","DOI":"10.3390\/jcm6010007"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1164\/rccm.200310-1441OC","volume":"169","author":"V Cottin","year":"2004","unstructured":"Cottin V, Plauchu H, Bayle JY et al (2004) Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 169:994\u20131000","journal-title":"Am J Respir Crit Care Med"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/ng1764","volume":"38","author":"PJ Coucke","year":"2006","unstructured":"Coucke PJ, Willaert A, Wessels MW et al (2006) Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 38:452\u2013457","journal-title":"Nat Genet"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bjp.0704331","volume":"134","author":"A Daugherty","year":"2001","unstructured":"Daugherty A, Manning MW, Cassis LA (2001) Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 134:865\u2013870","journal-title":"Br J Pharmacol"},{"key":"7_CR29","doi-asserted-by":"publisher","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","volume":"302","author":"RJ Davies","year":"2012","unstructured":"Davies RJ, Holmes AM, Deighton J et al (2012) BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol 302:L604\u2013L615","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7_CR30","unstructured":"Dietz H (1993) Marfan Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews((R)). Seattle (WA)"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/hmg\/4.suppl_1.1799","volume":"4","author":"HC Dietz","year":"1995","unstructured":"Dietz HC, Pyeritz RE (1995) Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 4:1799\u20131809","journal-title":"Hum Mol Genet"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.matbio.2006.04.004","volume":"25","author":"R Droguett","year":"2006","unstructured":"Droguett R, Cabello-Verrugio C, Riquelme C et al (2006) Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix biology : journal of the International Society for Matrix Biology 25:332\u2013341","journal-title":"Matrix biology : journal of the International Society for Matrix Biology"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"12477","DOI":"10.1074\/jbc.C100008200","volume":"276","author":"T Ebisawa","year":"2001","unstructured":"Ebisawa T, Fukuchi M, Murakami G et al (2001) Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276:12477\u201312480","journal-title":"J Biol Chem"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/01.HYP.23.5.587","volume":"23","author":"AD Everett","year":"1994","unstructured":"Everett AD, Tufro-Mcreddie A, Fisher A et al (1994) Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension 23:587\u2013592","journal-title":"Hypertension"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48:73\u201387","journal-title":"J Med Genet"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng XH, Derynck R (2005) Specificity and versatility in TGF-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659\u2013693","journal-title":"Annu Rev Cell Dev Biol"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cardiores.2005.06.009","volume":"68","author":"LA Fernandez","year":"2005","unstructured":"Fernandez LA, Sanz-Rodriguez F, Zarrabeitia R et al (2005) Blood outgrowth endothelial cells from hereditary Haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68:235\u2013248","journal-title":"Cardiovasc Res"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3121\/cmr.4.1.66","volume":"4","author":"LA Fernandez","year":"2006","unstructured":"Fernandez LA, Sanz-Rodriguez F, Blanco FJ et al (2006) Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway. Clin Med Res 4:66\u201378","journal-title":"Clin Med Res"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0895-7061(99)00152-1","volume":"13","author":"N Fukuda","year":"2000","unstructured":"Fukuda N, Hu WY, Kubo A et al (2000) Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells. Am J Hypertens 13:191\u2013198","journal-title":"Am J Hypertens"},{"key":"7_CR40","first-page":"477","volume":"19","author":"RK Fulbright","year":"1998","unstructured":"Fulbright RK, Chaloupka JC, Putman CM et al (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19:477\u2013484","journal-title":"AJNR Am J Neuroradiol"},{"key":"7_CR41","doi-asserted-by":"crossref","unstructured":"Gensemer C, Burks R, Kautz S et al (2020) Hypermobile Ehlers-Danlos syndromes: complex phenotypes, challenging diagnoses, and poorly understood causes. Dev Dyn","DOI":"10.1002\/dvdy.220"},{"key":"7_CR42","first-page":"4162","volume":"8","author":"LE Gentry","year":"1988","unstructured":"Gentry LE, Lioubin MN, Purchio AF et al (1988) Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 8:4162\u20134168","journal-title":"Mol Cell Biol"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.athoracsur.2010.12.060","volume":"91","author":"E Girdauskas","year":"2011","unstructured":"Girdauskas E, Schulz S, Borger MA et al (2011) Transforming growth factor-beta receptor type II mutation in a patient with bicuspid aortic valve disease and intraoperative aortic dissection. Ann Thorac Surg 91:e70\u2013e71","journal-title":"Ann Thorac Surg"},{"key":"7_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1053\/j.semtcvs.2005.06.001","volume":"17","author":"TG Gleason","year":"2005","unstructured":"Gleason TG (2005) Heritable disorders predisposing to aortic dissection. Semin Thorac Cardiovasc Surg 17:274\u2013281","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S et al (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK5 signaling. Mol Cell 12:817\u2013828","journal-title":"Mol Cell"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17:860\u2013871","journal-title":"Eur J Hum Genet"},{"key":"7_CR47","unstructured":"Greally MT (1993) Shprintzen-Goldberg Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews((R)). Seattle (WA)"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<202::AID-AJMG2>3.0.CO;2-S","volume":"76","author":"MT Greally","year":"1998","unstructured":"Greally MT, Carey JC, Milewicz DM et al (1998) Shprintzen-Goldberg syndrome: a clinical analysis. Am J Med Genet 76:202\u2013212","journal-title":"Am J Med Genet"},{"key":"7_CR49","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1161\/01.CIR.103.20.2461","volume":"103","author":"D Guo","year":"2001","unstructured":"Guo D, Hasham S, Kuang SQ et al (2001) Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103:2461\u20132468","journal-title":"Circulation"},{"key":"7_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117\u2013121","journal-title":"Science"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1101\/gad.12.2.186","volume":"12","author":"A Hata","year":"1998","unstructured":"Hata A, Lagna G, Massague J et al (1998) Smad6 inhibits BMP\/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12:186\u2013197","journal-title":"Genes Dev"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/08977194.2011.595411","volume":"29","author":"LJ Hawinkels","year":"2011","unstructured":"Hawinkels LJ, Ten Dijke P (2011) Exploring anti-TGF-beta therapies in cancer and fibrosis. Growth Factors 29:140\u2013152","journal-title":"Growth Factors"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216\u20131219","journal-title":"Science"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","volume":"261","author":"RA Ignotz","year":"1986","unstructured":"Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337\u20134345","journal-title":"J Biol Chem"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/39355","volume":"389","author":"T Imamura","year":"1997","unstructured":"Imamura T, Takase M, Nishihara A et al (1997) Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389:622\u2013626","journal-title":"Nature"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1161\/01.ATV.0000143384.69170.2d","volume":"24","author":"M Ishibashi","year":"2004","unstructured":"Ishibashi M, Egashira K, Zhao Q et al (2004) Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24:e174\u2013e178","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR57","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1074\/jbc.M209256200","volume":"278","author":"Z Isogai","year":"2003","unstructured":"Isogai Z, Ono RN, Ushiro S et al (2003) Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 278:2750\u20132757","journal-title":"J Biol Chem"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189\u2013195","journal-title":"Nat Genet"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11886-010-0083-z","volume":"12","author":"JA Jones","year":"2010","unstructured":"Jones JA, Ikonomidis JS (2010) The pathogenesis of aortopathy in Marfan syndrome and related diseases. Curr Cardiol Rep 12:99\u2013107","journal-title":"Curr Cardiol Rep"},{"key":"7_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000127437","volume":"45","author":"JA Jones","year":"2008","unstructured":"Jones JA, Barbour JR, Stroud RE et al (2008) Altered transforming growth factor-beta signaling in a murine model of thoracic aortic aneurysm. J Vasc Res 45:457\u2013468","journal-title":"J Vasc Res"},{"key":"7_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000151766","volume":"46","author":"JA Jones","year":"2009","unstructured":"Jones JA, Spinale FG, Ikonomidis JS (2009) Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 46:119\u2013137","journal-title":"J Vasc Res"},{"key":"7_CR62","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","volume":"366","author":"DP Judge","year":"2005","unstructured":"Judge DP, Dietz HC (2005) Marfan's syndrome. Lancet 366:1965\u20131976","journal-title":"Lancet"},{"key":"7_CR63","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12265-011-9314-y","volume":"4","author":"DP Judge","year":"2011","unstructured":"Judge DP, Rouf R, Habashi J et al (2011) Mitral valve disease in Marfan syndrome and related disorders. J Cardiovasc Transl Res 4:741\u2013747","journal-title":"J Cardiovasc Transl Res"},{"key":"7_CR64","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","volume":"6","author":"P Kavsak","year":"2000","unstructured":"Kavsak P, Rasmussen RK, Causing CG et al (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6:1365\u20131375","journal-title":"Mol Cell"},{"key":"7_CR65","first-page":"1375","volume":"25","author":"ES Kim","year":"2004","unstructured":"Kim ES, Kim MS, Moon A (2004) TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 25:1375\u20131382","journal-title":"Int J Oncol"},{"key":"7_CR66","doi-asserted-by":"publisher","first-page":"17647","DOI":"10.1074\/jbc.M908622199","volume":"275","author":"N Kimura","year":"2000","unstructured":"Kimura N, Matsuo R, Shibuya H et al (2000) BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275:17647\u201317652","journal-title":"J Biol Chem"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","volume":"245","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31\u201339","journal-title":"J Intern Med"},{"key":"7_CR68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajmg.a.31006","volume":"140","author":"K Kosaki","year":"2006","unstructured":"Kosaki K, Takahashi D, Udaka T et al (2006) Molecular pathology of Shprintzen-Goldberg syndrome. Am J Med Genet A 140:104\u2013108. author reply 109-110","journal-title":"Am J Med Genet A"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1541-7786.MCR-05-0140","volume":"4","author":"HJ Kwak","year":"2006","unstructured":"Kwak HJ, Park MJ, Cho H et al (2006) Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol Cancer Res 4:209\u2013220","journal-title":"Mol Cancer Res"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1083\/jcb.103.6.2403","volume":"103","author":"M Laiho","year":"1986","unstructured":"Laiho M, Saksela O, Andreasen PA et al (1986) Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103:2403\u20132410","journal-title":"J Cell Biol"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/jcp.1041210123","volume":"121","author":"DA Lawrence","year":"1984","unstructured":"Lawrence DA, Pircher R, Kryceve-Martinerie C et al (1984) Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 121:184\u2013188","journal-title":"J Cell Physiol"},{"key":"7_CR72","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","volume":"26","author":"MK Lee","year":"2007","unstructured":"Lee MK, Pardoux C, Hall MC et al (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26:3957\u20133967","journal-title":"EMBO J"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cardiores.2005.04.028","volume":"68","author":"M Letarte","year":"2005","unstructured":"Letarte M, Mcdonald ML, Li C et al (2005) Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1. Cardiovasc Res 68:155\u2013164","journal-title":"Cardiovasc Res"},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1097\/MIB.0b013e3182a8452e","volume":"19","author":"C Li","year":"2013","unstructured":"Li C, Flynn RS, Grider JR et al (2013) Increased activation of latent TGF-beta1 by alphaVbeta3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide. Inflamm Bowel Dis 19:2829\u20132839","journal-title":"Inflamm Bowel Dis"},{"key":"7_CR75","first-page":"69","volume":"70","author":"B Loeys","year":"2008","unstructured":"Loeys B, De Paepe A (2008) New insights in the pathogenesis of aortic aneurysms. Verh K Acad Geneeskd Belg 70:69\u201384","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"7_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys BL, Chen J, Neptune ER et al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275\u2013281","journal-title":"Nat Genet"},{"key":"7_CR77","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1056\/NEJMoa055695","volume":"355","author":"BL Loeys","year":"2006","unstructured":"Loeys BL, Schwarze U, Holm T et al (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788\u2013798","journal-title":"N Engl J Med"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1083\/jcb.124.4.557","volume":"124","author":"F Lopez-Casillas","year":"1994","unstructured":"Lopez-Casillas F, Payne HM, Andres JL et al (1994) Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 124:557\u2013568","journal-title":"J Cell Biol"},{"key":"7_CR79","unstructured":"Macri A, Wilson AM, Shafaat O et al. (2020) Osler-Weber-Rendu Disease. In: StatPearls. Treasure Island (FL)"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/sj.gt.3302016","volume":"10","author":"RA Mageed","year":"2003","unstructured":"Mageed RA, Prud'homme GJ (2003) Immunopathology and the gene therapy of lupus. Gene Ther 10:861\u2013874","journal-title":"Gene Ther"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P et al (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 175:8\u201326","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/35043051","volume":"1","author":"J Massague","year":"2000","unstructured":"Massague J (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1:169\u2013178","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA Mcallister","year":"1994","unstructured":"Mcallister KA, Grogg KM, Johnson DW et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345\u2013351","journal-title":"Nat Genet"},{"key":"7_CR84","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0002-9149(98)00364-6","volume":"82","author":"DM Milewicz","year":"1998","unstructured":"Milewicz DM, Chen H, Park ES et al (1998) Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms\/dissections. Am J Cardiol 82:474\u2013479","journal-title":"Am J Cardiol"},{"key":"7_CR85","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccl.2010.01.017","volume":"28","author":"DM Milewicz","year":"2010","unstructured":"Milewicz DM, Carlson AA, Regalado ES (2010) Genetic testing in aortic aneurysm disease: PRO. Cardiol Clin 28:191\u2013197","journal-title":"Cardiol Clin"},{"key":"7_CR86","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejmg.2013.12.004","volume":"57","author":"R Morissette","year":"2014","unstructured":"Morissette R, Merke DP, Mcdonnell NB (2014) Transforming growth factor-beta (TGF-beta) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome. Eur J Med Genet 57:95\u2013102","journal-title":"Eur J Med Genet"},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1242\/jcs.02554","volume":"118","author":"A Moustakas","year":"2005","unstructured":"Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118:3573\u20133584","journal-title":"J Cell Sci"},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"F278","DOI":"10.1152\/ajprenal.00139.2003","volume":"286","author":"T Naito","year":"2004","unstructured":"Naito T, Masaki T, Nikolic-Paterson DJ et al (2004) Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am J Physiol Renal Physiol 286:F278\u2013F287","journal-title":"Am J Physiol Renal Physiol"},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune ER, Frischmeyer PA, Arking DE et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407\u2013411","journal-title":"Nat Genet"},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1172\/JCI200422715","volume":"114","author":"CM Ng","year":"2004","unstructured":"Ng CM, Cheng A, Myers LA et al (2004) TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114:1586\u20131592","journal-title":"J Clin Invest"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0735-1097(89)90221-0","volume":"13","author":"P Nicod","year":"1989","unstructured":"Nicod P, Bloor C, Godfrey M et al (1989) Familial aortic dissecting aneurysm. J Am Coll Cardiol 13:811\u2013819","journal-title":"J Am Coll Cardiol"},{"key":"7_CR92","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","volume":"97","author":"SP Oh","year":"2000","unstructured":"Oh SP, Seki T, Goss KA et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97:2626\u20132631","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.4049\/jimmunol.160.5.2539","volume":"160","author":"K Ohtsuka","year":"1998","unstructured":"Ohtsuka K, Gray JD, Stimmler MM et al (1998) Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J Immunol 160:2539\u20132545","journal-title":"J Immunol"},{"key":"7_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ajmg.c.30069","volume":"139","author":"H Pannu","year":"2005","unstructured":"Pannu H, Tran-Fadulu V, Milewicz DM (2005) Genetic basis of thoracic aortic aneurysms and aortic dissections. Am J Med Genet C Semin Med Genet 139:10\u201316","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"7_CR95","first-page":"9","volume":"38","author":"SH Park","year":"2005","unstructured":"Park SH (2005) Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 38:9\u201316","journal-title":"J Biochem Mol Biol"},{"key":"7_CR96","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/qjmed\/hci115","volume":"98","author":"G Pasculli","year":"2005","unstructured":"Pasculli G, Quaranta D, Lenato GM et al (2005) Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia. QJM 98:757\u2013763","journal-title":"QJM"},{"key":"7_CR97","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/hep.23144","volume":"50","author":"E Patsenker","year":"2009","unstructured":"Patsenker E, Popov Y, Stickel F et al (2009) Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology 50:1501\u20131511","journal-title":"Hepatology"},{"key":"7_CR98","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira L, Lee SY, Gayraud B et al (1999) Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 96:3819\u20133823","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/jmg.33.6.441","volume":"33","author":"M Piantanida","year":"1996","unstructured":"Piantanida M, Buscarini E, Dellavecchia C et al (1996) Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33:441\u2013443","journal-title":"J Med Genet"},{"key":"7_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1750-1172-6-80","volume":"6","author":"RJ Pignolo","year":"2011","unstructured":"Pignolo RJ, Shore EM, Kaplan FS (2011) Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 6:80","journal-title":"Orphanet J Rare Dis"},{"key":"7_CR101","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.1320320302","volume":"32","author":"H Plauchu","year":"1989","unstructured":"Plauchu H, De Chadarevian JP, Bideau A et al (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291\u2013297","journal-title":"Am J Med Genet"},{"key":"7_CR102","first-page":"271","volume":"2","author":"P Pomianowski","year":"2013","unstructured":"Pomianowski P, Elefteriades JA (2013) The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg 2:271\u2013279","journal-title":"Ann Cardiothorac Surg"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/gtmb.2019.0064","volume":"23","author":"MK Pope","year":"2019","unstructured":"Pope MK, Ratajska A, Johnsen H et al (2019) Diagnostics of hereditary connective tissue disorders by genetic next-generation sequencing. Genet Test Mol Biomarkers 23:783\u2013790","journal-title":"Genet Test Mol Biomarkers"},{"key":"7_CR104","doi-asserted-by":"crossref","unstructured":"Pyeritz RE (2016) Recent Progress in understanding the natural and clinical histories of the Marfan syndrome. Trends Cardiovascul Med 26:423-428","DOI":"10.1016\/j.tcm.2015.12.003"},{"key":"7_CR105","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1357-2725(98)00109-5","volume":"31","author":"F Ramirez","year":"1999","unstructured":"Ramirez F, Pereira L (1999) The fibrillins. Int J Biochem Cell Biol 31:255\u2013259","journal-title":"Int J Biochem Cell Biol"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0945-053X(03)00002-7","volume":"22","author":"F Ramirez","year":"2003","unstructured":"Ramirez F, Rifkin DB (2003) Cell signaling events: a view from the matrix. Matrix Biol 22:101\u2013107","journal-title":"Matrix Biol"},{"key":"7_CR107","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ceb.2009.05.005","volume":"21","author":"F Ramirez","year":"2009","unstructured":"Ramirez F, Rifkin DB (2009) Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr Opin Cell Biol 21:616\u2013622","journal-title":"Curr Opin Cell Biol"},{"key":"7_CR108","doi-asserted-by":"crossref","unstructured":"Reed NI, Jo H, Chen C et al. (2015) The alphavbeta1 integrin plays a critical in vivo role in tissue fibrosis. Science translational medicine 7:288ra279","DOI":"10.1126\/scitranslmed.aaa5094"},{"key":"7_CR109","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trsl.2008.06.002","volume":"152","author":"MC Rico","year":"2008","unstructured":"Rico MC, Manns JM, Driban JB et al (2008) Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis. Transl Res 152:95\u201398","journal-title":"Transl Res"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/157016110791112296","volume":"8","author":"MC Rico","year":"2010","unstructured":"Rico MC, Rough JJ, Del Carpio-Cano FE et al (2010) The axis of thrombospondin-1, transforming growth factor beta and connective tissue growth factor: an emerging therapeutic target in rheumatoid arthritis. Curr Vasc Pharmacol 8:338\u2013343","journal-title":"Curr Vasc Pharmacol"},{"key":"7_CR111","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ajmg.a.30431","volume":"135","author":"PN Robinson","year":"2005","unstructured":"Robinson PN, Neumann LM, Demuth S et al (2005) Shprintzen-Goldberg syndrome: fourteen new patients and a clinical analysis. Am J Med Genet A 135:251\u2013262","journal-title":"Am J Med Genet A"},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","volume":"111","author":"J Rodriguez-Vita","year":"2005","unstructured":"Rodriguez-Vita J, Sanchez-Lopez E, Esteban V et al (2005) Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111:2509\u20132517","journal-title":"Circulation"},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1242\/dev.129.12.3009","volume":"129","author":"BL Roman","year":"2002","unstructured":"Roman BL, Pham VN, Lawson ND et al (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129:3009\u20133019","journal-title":"Development"},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/brain\/aws351","volume":"136","author":"P Roth","year":"2013","unstructured":"Roth P, Silginer M, Goodman SL et al (2013) Integrin control of the transforming growth factor-beta pathway in glioblastoma. Brain 136:564\u2013576","journal-title":"Brain"},{"key":"7_CR115","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/01.RES.0000095246.40391.3B","volume":"93","author":"T Seki","year":"2003","unstructured":"Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93:682\u2013689","journal-title":"Circ Res"},{"key":"7_CR116","doi-asserted-by":"publisher","first-page":"19327","DOI":"10.1074\/jbc.M314048200","volume":"279","author":"N Selvamurugan","year":"2004","unstructured":"Selvamurugan N, Kwok S, Alliston T et al (2004) Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J Biol Chem 279:19327\u201319334","journal-title":"J Biol Chem"},{"key":"7_CR117","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685\u2013700","journal-title":"Cell"},{"key":"7_CR118","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66\u201367","journal-title":"Am J Med Genet"},{"key":"7_CR119","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1160\/TH07-01-0064","volume":"98","author":"CL Shovlin","year":"2007","unstructured":"Shovlin CL, Sulaiman NL, Govani FS et al (2007) Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism. Thromb Haemost 98:1031\u20131039","journal-title":"Thromb Haemost"},{"key":"7_CR120","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/thx.2007.087452","volume":"63","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL, Jackson JE, Bamford KB et al (2008) Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 63:259\u2013266","journal-title":"Thorax"},{"key":"7_CR121","first-page":"65","volume":"2","author":"RJ Shprintzen","year":"1982","unstructured":"Shprintzen RJ, Goldberg RB (1982) A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias. J Craniofac Genet Dev Biol 2:65\u201374","journal-title":"J Craniofac Genet Dev Biol"},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng0296-209","volume":"12","author":"S Sood","year":"1996","unstructured":"Sood S, Eldadah ZA, Krause WL et al (1996) Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 12:209\u2013211","journal-title":"Nat Genet"},{"key":"7_CR123","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/ncb1780","volume":"10","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, Thakur N, Grimsby S et al (2008) The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10:1199\u20131207","journal-title":"Nat Cell Biol"},{"key":"7_CR124","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s004410051283","volume":"296","author":"M Stander","year":"1999","unstructured":"Stander M, Naumann U, Wick W et al (1999) Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296:221\u2013227","journal-title":"Cell Tissue Res"},{"key":"7_CR125","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1074\/jbc.M007609200","volume":"276","author":"S Stefansson","year":"2001","unstructured":"Stefansson S, Petitclerc E, Wong MK et al (2001) Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J Biol Chem 276:8135\u20138141","journal-title":"J Biol Chem"},{"key":"7_CR126","doi-asserted-by":"publisher","first-page":"E284","DOI":"10.1002\/humu.20871","volume":"29","author":"C Stheneur","year":"2008","unstructured":"Stheneur C, Collod-Beroud G, Faivre L et al (2008) Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat 29:E284\u2013E295","journal-title":"Hum Mutat"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.1016\/S0021-9258(18)68776-9","volume":"263","author":"A Superti-Furga","year":"1988","unstructured":"Superti-Furga A, Gugler E, Gitzelmann R et al (1988) Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen. J Biol Chem 263:6226\u20136232","journal-title":"J Biol Chem"},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jvs.2012.09.067","volume":"57","author":"J Sylvan","year":"2013","unstructured":"Sylvan J, Greenberg RK, Mastracci TM et al (2013) Treatment of a patient with vertebral and subclavian aneurysms in the setting of a TGFBR2 mutation. J Vasc Surg 57:1116\u20131119","journal-title":"J Vasc Surg"},{"key":"7_CR129","first-page":"336","volume":"112","author":"L Sys","year":"2005","unstructured":"Sys L, Van Den Hoogen FJ (2005) Rendu-Osler-Weber disease. Ned Tijdschr Tandheelkd 112:336\u2013339","journal-title":"Ned Tijdschr Tandheelkd"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJM200108023450503","volume":"345","author":"RC Trembath","year":"2001","unstructured":"Trembath RC, Thomson JR, Machado RD et al (2001) Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:325\u2013334","journal-title":"N Engl J Med"},{"key":"7_CR131","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ng.744","volume":"43","author":"IM Van De Laar","year":"2011","unstructured":"Van De Laar IM, Oldenburg RA, Pals G et al (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121\u2013126","journal-title":"Nat Genet"},{"key":"7_CR132","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/jmedgenet-2011-100382","volume":"49","author":"IM Van De Laar","year":"2012","unstructured":"Van De Laar IM, Van Der Linde D, Oei EH et al (2012) Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 49:47\u201357","journal-title":"J Med Genet"},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1600-0625.2007.00648.x","volume":"17","author":"MA Van Steensel","year":"2008","unstructured":"Van Steensel MA, Van Geel M, Parren LJ et al (2008) Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2. Exp Dermatol 17:362\u2013365","journal-title":"Exp Dermatol"},{"key":"7_CR134","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.amjmed.2003.08.030","volume":"116","author":"Y Von Kodolitsch","year":"2004","unstructured":"Von Kodolitsch Y, Nienaber CA, Dieckmann C et al (2004) Chest radiography for the diagnosis of acute aortic syndrome. Am J Med 116:73\u201377","journal-title":"Am J Med"},{"key":"7_CR135","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/ar1504","volume":"7","author":"SM Wahl","year":"2005","unstructured":"Wahl SM, Chen W (2005) Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 7:62\u201368","journal-title":"Arthritis Res Ther"},{"key":"7_CR136","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/thorax.55.8.685","volume":"55","author":"GM Wallace","year":"2000","unstructured":"Wallace GM, Shovlin CL (2000) A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 55:685\u2013690","journal-title":"Thorax"},{"key":"7_CR137","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cytogfr.2006.01.001","volume":"17","author":"S Werner","year":"2006","unstructured":"Werner S, Alzheimer C (2006) Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 17:157\u2013171","journal-title":"Cytokine Growth Factor Rev"},{"key":"7_CR138","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.RES.0000126047.82846.20","volume":"94","author":"J West","year":"2004","unstructured":"West J, Fagan K, Steudel W et al (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94:1109\u20131114","journal-title":"Circ Res"},{"key":"7_CR139","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/BST0340761","volume":"34","author":"SJ Wicks","year":"2006","unstructured":"Wicks SJ, Grocott T, Haros K et al (2006) Reversible ubiquitination regulates the Smad\/TGF-beta signalling pathway. Biochem Soc Trans 34:761\u2013763","journal-title":"Biochem Soc Trans"},{"key":"7_CR140","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.1158\/0008-5472.CAN-05-1522","volume":"65","author":"MC Wilkes","year":"2005","unstructured":"Wilkes MC, Mitchell H, Penheiter SG et al (2005) Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65:10431\u201310440","journal-title":"Cancer Res"},{"key":"7_CR141","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s001099900028","volume":"77","author":"G Wolf","year":"1999","unstructured":"Wolf G, Ziyadeh FN, Stahl RA (1999) Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med 77:556\u2013564","journal-title":"J Mol Med"},{"key":"7_CR142","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/0092-8674(92)90395-S","volume":"71","author":"JL Wrana","year":"1992","unstructured":"Wrana JL, Attisano L, Carcamo J et al (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003\u20131014","journal-title":"Cell"},{"key":"7_CR143","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","volume":"47","author":"W Xiong","year":"2008","unstructured":"Xiong W, Knispel RA, Dietz HC et al (2008) Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. J Vasc Surg 47:166\u2013172. discussion 172","journal-title":"J Vasc Surg"},{"key":"7_CR144","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","volume":"110","author":"W Xiong","year":"2012","unstructured":"Xiong W, Meisinger T, Knispel R et al (2012) MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome. Circ Res 110:e92\u2013e101","journal-title":"Circ Res"},{"key":"7_CR145","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.molcel.2008.09.002","volume":"31","author":"M Yamashita","year":"2008","unstructured":"Yamashita M, Fatyol K, Jin C et al (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell 31:918\u2013924","journal-title":"Mol Cell"},{"key":"7_CR146","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcp.20948","volume":"211","author":"C Yan","year":"2007","unstructured":"Yan C, Boyd DD (2007) Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211:19\u201326","journal-title":"J Cell Physiol"},{"key":"7_CR147","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/carcin\/bgm195","volume":"28","author":"HJ You","year":"2007","unstructured":"You HJ, Bruinsma MW, How T et al (2007) The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis 28:2491\u20132500","journal-title":"Carcinogenesis"},{"key":"7_CR148","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1093\/emboj\/16.22.6659","volume":"16","author":"X Yuan","year":"1997","unstructured":"Yuan X, Downing AK, Knott V et al (1997) Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils. EMBO J 16:6659\u20136666","journal-title":"EMBO J"},{"key":"7_CR149","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12079-015-0307-5","volume":"9","author":"KA Zeyer","year":"2015","unstructured":"Zeyer KA, Reinhardt DP (2015) Fibrillin-containing microfibrils are key signal relay stations for cell function. J Cell Commun Signal 9:309\u2013325","journal-title":"J Cell Commun Signal"}],"container-title":["Advances in Experimental Medicine and Biology","Progress in Heritable Soft Connective Tissue Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-80614-9_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:03:54Z","timestamp":1770123834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-80614-9_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030806132","9783030806149"],"references-count":149,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-80614-9_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"23 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}